Cargando…

Regulating the effects of GPR21, a novel target for type 2 diabetes

Type 2 diabetes is a chronic metabolic disorder primarily caused by insulin resistance to which obesity is a major contributor. Expression levels of an orphan G protein-coupled receptor (GPCR), GPR21, demonstrated a trend towards a significant increase in the epididymal fat pads of wild type high fa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Leonard, Siobhán, Kinsella, Gemma K., Benetti, Elisa, Findlay, John B. C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4886680/ https://www.ncbi.nlm.nih.gov/pubmed/27243589 http://dx.doi.org/10.1038/srep27002

Ejemplares similares

GPR21 Inhibition Increases Glucose-Uptake in HepG2 Cells
por: Kinsella, Gemma K., et al.
Publicado: (2021)

Structure based prediction of a novel GPR120 antagonist based on pharmacophore screening and molecular dynamics simulations
por: Pal, Ajay, et al.
Publicado: (2021)

Activation of GPR40 as a Therapeutic Target for the Treatment of Type 2 Diabetes
por: Burant, Charles F.
Publicado: (2013)

Glycine Effect on the Expression Profile of Orphan Receptors GPR21, GPR26, GPR39, GPR82 and GPR6 in a Model of Inflammation in 3T3-L1 Cells
por: Gutiérrez-Rojas, Rocío Alejandra, et al.
Publicado: (2022)

GPR35 as a Novel Therapeutic Target
por: MacKenzie, A. E., et al.
Publicado: (2011)

Thiazolidinedione derivatives as novel GPR120 agonists for the treatment of type 2 diabetes
por: Wang, Xuekun, et al.
Publicado: (2022)

Novel GPR120 Agonists with Improved Pharmacokinetic Profiles for the Treatment of Type 2 Diabetes
por: Ji, Guoxia, et al.
Publicado: (2021)

On-target and off-target effects of novel orthosteric and allosteric activators of GPR84
por: Mancini, Sarah J., et al.
Publicado: (2019)

Cryo-EM structures of orphan GPR21 signaling complexes
por: Lin, Xi, et al.
Publicado: (2023)

Gpr63 is a modifier of microcephaly in Ttc21b mouse mutants
por: Snedeker, John, et al.
Publicado: (2019)

Characterization of Four Orphan Receptors (GPR3, GPR6, GPR12 and GPR12L) in Chickens and Ducks and Regulation of GPR12 Expression in Ovarian Granulosa Cells by Progesterone
por: Li, Zejiao, et al.
Publicado: (2021)

Interactions of the Melanocortin-4 Receptor with the Peptide Agonist NDP-MSH
por: Chapman, Kathryn L., et al.
Publicado: (2010)

In Vivo Efficacy of HD0471953: A Novel GPR119 Agonist for the Treatment of Type 2 Diabetes Mellitus
por: Kim, So Ra, et al.
Publicado: (2013)

Cryo‐EM structure of orphan G protein‐coupled receptor GPR21
por: Wong, Thian‐Sze, et al.
Publicado: (2023)

Regulation of Energy Homeostasis by GPR41
por: Inoue, Daisuke, et al.
Publicado: (2014)

Targeting Oxidative Stress: Novel Coumarin-Based Inverse Agonists of GPR55
por: Apweiler, Matthias, et al.
Publicado: (2021)

Coordination of GPR40 and Ketogenesis Signaling by Medium Chain Fatty Acids Regulates Beta Cell Function
por: Pujol, Julien Benjamin, et al.
Publicado: (2018)

GPR68: An Emerging Drug Target in Cancer
por: Wiley, Shu Z., et al.
Publicado: (2019)

TRIpartite Motif 21 (TRIM21) Differentially Regulates the Stability of Interferon Regulatory Factor 5 (IRF5) Isoforms
por: Lazzari, Elisa, et al.
Publicado: (2014)

Regulation of Energy Homeostasis via GPR120
por: Ichimura, Atsuhiko, et al.
Publicado: (2014)

Gpr158 mediates osteocalcin’s regulation of cognition
por: Khrimian, Lori, et al.
Publicado: (2017)

GPR37 and Related Receptors: Disease Regulation
por: Marazziti, Daniela
Publicado: (2023)

Pharmacometric Approaches to Guide Dose Selection of the Novel GPR40 Agonist TAK-875 in Subjects With Type 2 Diabetes Mellitus
por: Naik, H, et al.
Publicado: (2013)

Discovery of Novel and Selective G-Protein Coupled Receptor 120 (GPR120) Agonists for the Treatment of Type 2 Diabetes Mellitus
por: Wang, Xuekun, et al.
Publicado: (2022)

GPR65, a novel regulator of helper T‐cell polarization in inflammatory bowel disease
por: Hathaway‐Schrader, Jessica D., et al.
Publicado: (2022)

Sodium acetate regulates milk fat synthesis through the activation of GPR41/GPR43 signaling pathway
por: Qi, Yingao, et al.
Publicado: (2023)

GPR41 and GPR43 in Obesity and Inflammation – Protective or Causative?
por: Ang, Zhiwei, et al.
Publicado: (2016)

The therapeutic potential of orphan GPCRs, GPR35 and GPR55
por: Shore, Derek M., et al.
Publicado: (2015)

Ginseng Gintonin Contains Ligands for GPR40 and GPR55
por: Cho, Yeon-Jin, et al.
Publicado: (2020)

FFA4/GPR120: Pharmacology and Therapeutic Opportunities
por: Milligan, Graeme, et al.
Publicado: (2017)

GPR120 is an important inflammatory regulator in the development of osteoarthritis
por: Chen, Yuanfeng, et al.
Publicado: (2018)

The emerging roles of GPR158 in the regulation of the endocrine system
por: Lin, Jinju, et al.
Publicado: (2022)

G-Protein Coupled Receptor 30 (GPR30): A Novel Regulator of Endothelial Inflammation
por: Chakrabarti, Subhadeep, et al.
Publicado: (2012)

Potential Metabolic and Behavioural Roles of the Putative Endo- cannabinoid Receptors GPR18, GPR55 and GPR119 in Feeding
por: Ramírez-Orozco, Ricardo E., et al.
Publicado: (2019)

The lipid sensor GPR120 promotes brown fat activation and FGF21 release from adipocytes
por: Quesada-López, Tania, et al.
Publicado: (2016)

Pan-Cancer Analysis and Drug Formulation for GPR139 and GPR142
por: Kaushik, Aman Chandra, et al.
Publicado: (2021)

GPR120/FFAR4 Pharmacology: Focus on Agonists in Type 2 Diabetes Mellitus Drug Discovery
por: Carullo, Gabriele, et al.
Publicado: (2021)

Peptide-guided targeting of GPR55 for anti-cancer therapy
por: Mangini, Maria, et al.
Publicado: (2016)

Potential roles of GPR120 and its agonists in the management of diabetes
por: Zhang, Dan, et al.
Publicado: (2014)

Role of GPR55 during Axon Growth and Target Innervation
por: Cherif, Hosni, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_7n9eqr0eogg5nv5j2f7ae4shl4